Status:

COMPLETED

Associations Between General Movements Assessments and Cognitive Development

Lead Sponsor:

Kahramanmaras Sutcu Imam University

Conditions:

Cerebral Palsy

Infant Development

Eligibility:

All Genders

25-42 years

Brief Summary

High risk infant is defined as infant with a negative history of environmental and biological factors, which can lead to neuromotor development problems. It is a heterogeneous group of premature infan...

Detailed Description

High-risk of infant follow-up programs provide guidance for the treatment of neurodevelopmental delays and deterioration in terms of early development. Three methods with the best predictable validity...

Eligibility Criteria

Inclusion

  • Having periventricular hemorrhage, ICH stages 2, 3, 4, cystic PVL, stage 3 HIE, kernicterus, perinatal asphyxia, chronic lung disease, RDS, BPD, long-term oxygen (7 days), \>24 hours mechanical ventilator (MV) support, 5th minute Apgar Score \<3, neonatal sepsis, necrotizing enterocolitis (NEC), retinopathy of prematurity (ROP), gestation age \<32 weeks, and prematurity due to preterm/multiple births\<1500 gr.

Exclusion

  • Infants with congenital malformation (Spina Bifida, Congenital Muscular Torticollis, Arthrogriposis Multiplex Congenita etc.)
  • Infants diagnosed with metabolic and genetic diseases (Down Syndrome,Spinal Muscular Atrophy, Duchenne Muscular Dystrophy etc.)
  • Infants still intubated and mechanical ventilator dependent at postterm 3 months

Key Trial Info

Start Date :

August 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 30 2021

Estimated Enrollment :

63 Patients enrolled

Trial Details

Trial ID

NCT05217056

Start Date

August 1 2020

End Date

September 30 2021

Last Update

February 1 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hatice Adıgüzel

Kahramanmaraş, Dulkadiroglu, Turkey (Türkiye), 46100